Trials / Not Yet Recruiting
Not Yet RecruitingNCT07093775
Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence Score
Prognostic Implication of Tumor Grade in Patients With Node-negative Breast Cancer Aged ≤ 50 Years With 21-gene Recurrence Scores of 11-25
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,000 (estimated)
- Sponsor
- Gangnam Severance Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
To evaluated the prognostic significance of tumor grade in patients with node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2-negative breast cancers treated according to RS-guided strategies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Tumor grade (I or II vs. III) | We compared the prognosis according to the tumor grade stratified by 21-gene recurrence score |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2025-12-01
- Completion
- 2026-03-01
- First posted
- 2025-07-30
- Last updated
- 2025-07-30
Source: ClinicalTrials.gov record NCT07093775. Inclusion in this directory is not an endorsement.